Global Insulin Delivery Pen Market 2018

Insulin Delivery Pen Market is expected to exceed US$ 14 Billion across the ten major markets (10MM) by 2025.
The report “Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 – 2017) and Future Forecast (2018 – 2025)” offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM). The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.
Key Findings:
• Germany accounted for 15% of the insulin delivery pen market in 2017
• China dominates the reusable insulin delivery pen market
• Reusable insulin delivery pen has the highest volume share in the overall insulin delivery pen market
• Disposable insulin delivery pen is expected to register a faster value growth during 2018-2025
• Japan is the third largest insulin delivery pen market
• Flexpen, Solostar and KwikPen are the leading brand in the insulin delivery pen sector
The Latest Industry Data Included in this Report:
• Diabetes Population in 10 major market(10MM) 2011-2025
• Insulin Users Insights in 10 major market(10MM) 2011-2025
• Overall Insulin Delivery Pen Users, 2011-2025
• Overall Insulin Delivery Pen Market Size, 2011-2025
• Insulin Delivery Pen Market Size by Product Segments, 2011-2025
• Growth Rates of the Overall Market and Different Product Segments, 2011-2025
• Shares of Different Product Segments of the Overall Market, 2011- 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers
   and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
  Product Portfolios and Recent Development
The Report Facilitates Answer the Subsequent Questions:
• What is the size of the insulin delivery pen market in 10 major market(10MM)?
• How much reusable and disposable pen users in 10 major market(10MM)?
• How is the insulin delivery pen market divided into two different types of segments?
• How are the overall market and segments types growing?
• How is the market predicted to develop in the future?
• Who are the market players?
Advertisements

Supplemental Biologics License Application for .5 mL Influenza Vaccine in Children 6-35 Months Accepted by FDA

Source: http://www.contagionlive.com/

The US Food and Drug Administration (FDA) accepted for review a supplemental Biologics License Application seeking to expand the age indication of the 0.5 mL dose of Sanofi Pasteur’s influenza vaccine (Fluzone Quadrivalent) to include children between 6 and 35 months of age.

The target action date is January 28, 2019, per the Prescription Drug User Fee Act.

“We are one step closer to potentially offering clinicians the option to use 0.5 mL dose of Fluzone Quadrivalent vaccine with all of their eligible pediatric patients 6 months of age and older,” David Greenberg, MD, associate vice president and regional medical head of North American, Sanofi Pasteur, said in a statement.

Visit for More Reports on Pediatric Vaccine: http://www.dpiresearch.com/

Precise study on United States Pediatric Vaccine Market including Key Players, Industry Growth, Size, Share, Trends, Forecast 2025

Single User License

$900.00

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.
“Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025” provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Furthermore, this report provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=134
The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.
The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Sanofi Pasteur
• GlaxoSmithKline(GSK)
• Merck & Co.
• Pfizer Inc
• Grifols
Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:
• Diphtheria, Tetanus & Pertussis (DTap)
• Hepatitis A
• Varicella/Chicken Pox
• Pneumococcal
• Haemophilus Influenzae Type B (HIB)
• Polio
• Rotavirus
• Hepatitis B
• Influenza Pediatric
• Measles, Mumps & Rubella (MMR)
The Latest Industry Data Included in this Report:
• United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025
• United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 – 2025
• United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025
• 10 Pediatric Vaccines Doses Administered (Volume),2010 – 2025
• Number of Children Being Vaccinated (Volume)2010 – 2025
• 10 Pediatric Vaccines Market Size and Forecast(Value),2010 – 2025
• Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
   Product Portfolios and Latest Recent Development and Trends
The Following Key Questions have been Addressed in the Report:
• What is the size of the United States pediatric vaccines market during 2010 -2025?
• How will each segment of the United States pediatric vaccines market grow during the forecast
   period and what will be the revenue generated by each of the segments by the end of 2025?
• Which major pediatric vaccines provides highest market share?
• How much number of children being vaccinated during 2010 – 2025?
• How are the overall market and segments types growing?
• What are the major market drivers and inhibitors in the United States pediatric vaccines market?
• Who are the key players in the United States pediatric vaccines market and what are their contributions?

Growth Opportunities in “United States Influenza Vaccine Market” Industry: Trends, Forecast and Opportunity Analysis by Top Manufacturers, Trends, Application by 2022

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.
Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=90
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.
The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.
Major and Promising Vaccine covered in the report are as follows:
Fluzone High–Dose
Fluzone Quadrivalent
Intradermal (ID) Trivalent
Vaxigrip
Fluarix Quadrivalent
Flulaval Quadrivalent
Fluenz Tetra
FluMist Quadrivalent
Flublok
VN–100
M–001
VAX–2012Q
TAK – 850
Flucelvax Quadrivalent
Afluria Quadrivalent
Agrippal
Fluad
Fluvirin
Fluvax
Key Companies Covered in the Report are as follows:
Sanofi Pasteur
GlaxoSmithKline(GSK)
Seqirus
AstraZenecca
Protein Sciences Corporation
Novavax
Daiichi–Sankyo
Mitsubishi Tanabe Pharma
BiondVax Pharmaceuticals Ltd
VaxInnate